Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $85,981 - $138,727
-5,121 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$15.78 - $24.77 $80,809 - $126,847
5,121 New
5,121 $85,000
Q2 2021

Aug 13, 2021

SELL
$19.4 - $27.42 $145,500 - $205,650
-7,500 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$25.02 - $54.99 $187,650 - $412,425
7,500 New
7,500 $194,000
Q4 2020

Feb 08, 2021

SELL
$41.04 - $56.79 $58,153 - $80,471
-1,417 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$36.42 - $57.0 $51,607 - $80,769
1,417 New
1,417 $58,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.